Describing Patient Characteristics, Treatment Patterns, and Disease Burden Among Patients with Alopecia Areata in Mexico: A Secondary Analysis of the Adelphi Real World Alopecia Areata Disease Specific Programme - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Patient Profiles, Treatment Approaches, and Disease Burden in Alopecia Areata in Mexico: Secondary Analysis of the Adelphi Real World Disease-Specific Programme

  • By

  • Luis E. Sanchez-Duenas

  • Ashley S. Cha-Silva

  • Peter Anderson

  • Martha Alicia Aceves-Villalvazo

  • Veronica J. Guajardo-Barron

  • Carlos A. Barrera-Ochoa

  • Raul A. Becerra-Cerecedo

  • Jorge Alberto Barragan Garfias

  • William Jones

  • Samantha K. Kurosky

  • Nelly A. Espinoza-Gonzalez

  • October 7, 2026

Share

  • 1

    This secondary analysis used linked physician and patient surveys collected in Mexico from October 2024 through April 2025 to characterize adult alopecia areata burden and treatment.

  • 2

    Disease burden increased with physician-assessed severity, with moderate to severe/very severe disease associated with more extensive scalp and nonscalp hair loss.

  • 3

    Patients with moderate to severe/very severe alopecia areata reported greater quality-of-life impairment and higher anxiety and depression levels than those with mild disease.

  • 4

    Conventional treatments, particularly corticosteroids, predominated across severity groups, while advanced therapies were infrequently used, including for severe/very severe disease.

  • 5

    Patients with severe/very severe disease reported lower treatment satisfaction, and the authors identified limited advanced therapy use and potential access and reimbursement barriers as unmet needs i

Original Source(s)

Describing Patient Characteristics, Treatment Patterns, and Disease Burden Among Patients with Alopecia Areata in Mexico: A Secondary Analysis of the Adelphi Real World Alopecia Areata Disease Specific Programme

  • by Luis E. Sanchez-Duenas, Ashley S. Cha-Silva, Peter Anderson, Martha Alicia Aceves-Villalvazo, Veronica J. Guajardo-Barron, Carlos A. Barrera-Ochoa, Raul A. Becerra-Cerecedo, Jorge Alberto Barragan Garfias, William Jones, Samantha K. Kurosky, Nelly A. Espinoza-Gonzalez

  • October 7, 2026

Related Content

Frequent oropharyngeal detection of Treponema pallidum DNA in patients with syphilis: a cross-sectional study of three anatomical sampling sites

Seminal fibrils may facilitate mpox infection

Seminal fluid increased mpox virus infection across primary cells and viral isolates, with semen-derived amyloid fibrils promoting viral attachment and uptake.

Photodynamic therapy gains FDA approval for superficial BCC

Phase 3 trial data showed greater clinical and histological clearance than with placebo photodynamic therapy.